Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06511037 · ClinicalTrials.gov registry record · Early Phase 1
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
A Early Phase 1 study of Gastrointestinal Cancer and Peritoneal Carcinomatosis, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06511037 is a Early Phase 1 study of Gastrointestinal Cancer and Peritoneal Carcinomatosis that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 10 participants, below the 234-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06511037, a Early Phase 1 study of Gastrointestinal Cancer and Peritoneal Carcinomatosis, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot, single-arm, open label study to evaluate the ability of CYTALUX™ (pafolacianine) to help identify cancerous lesions in subjects with gastrointestinal cancers and peritoneal carcinomatosis during cytoreductive surgery.
Conditions Studied
Interventions
- DRUG Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging
Study Locations (1)
California
- Chao Family Comprehensive Cancer Center, University of California, Irvine - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-11-13 |
| Est. Completion | 2027-11-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06511037
The ClinicalTrials.gov registry entry for NCT06511037 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 234-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target (96% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gastrointestinal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging is the first listed.
NCT06511037 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06511037 about?
NCT06511037 is a clinical study titled "PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis". This is a pilot, single-arm, open label study to evaluate the ability of CYTALUX™ (pafolacianine) to help identify cancerous lesions in subjects with gastrointestinal cancers and peritoneal carcinomatosis during cytoreductive surgery.
What is the current status of trial NCT06511037?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2024-11-13. Estimated completion is 2027-11-30.
What conditions does trial NCT06511037 study?
This clinical trial studies the following conditions: Gastrointestinal Cancer, Peritoneal Carcinomatosis.
What interventions are being tested in trial NCT06511037?
The interventions under investigation include: Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging (DRUG).
Who is sponsoring clinical trial NCT06511037?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06511037 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
Improving Comprehensive Care of Cancer Patients
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.